Four things to know:
1. The company saw a 5.3% revenue increase year-over-year with $8 billion.
2. Medtronic’s neuroscience portfolio saw a 4.7% year-over-year increase with $2.28 billion.
3. The cranial and spinal technologies segment saw a 7% increase year-over-year with $1.2 billion.
4. Medtronic raised its revenue growth guidance to 4.75%.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
